| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Dec 18, 2018 | 58.90 | 58.90 | 56.00 | 56.00 | 10,137 |
| Dec 17, 2018 | 58.24 | 59.00 | 56.00 | 59.00 | 15,772 |
| Dec 14, 2018 | 59.00 | 59.00 | 56.00 | 58.20 | 23,825 |
| Dec 13, 2018 | 58.00 | 61.10 | 57.10 | 57.10 | 153,690 |
| Dec 12, 2018 | 65.50 | 65.50 | 59.50 | 61.00 | 128,604 |
| Name | Circassia Pharmaceuticals | Epic | CIR |
|---|---|---|---|
| ISIN | GB00BJVD3B28 | Currency | GBX |
| Type | Equity | Trading Segment | SSMM |
| Record Status | Active | Trading Status | Regular Trading |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 5,000 | Prev Close | 56.00 |
| Shares in Issue (m) | 357.30 | Market Cap (£m) | 200.09 |
| PE Ratio | -1.81 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -31.00 | EPS Growth (%) | 35.42 |
| PEG | -0.05 | DPS Growth (%) | n/a |
| ROCE | -30.57 | Net Gearing | 33.08 |
| Quick Ratio | 2.76 | Current Ratio | 2.92 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 18 Dec | Peel Hunt | Buy | 56.55 | 120.00 | - | Reiterates |
| 12 Dec | Peel Hunt | Buy | 56.55 | 120.00 | - | Reiterates |
| 06 Dec | Peel Hunt | Buy | 56.55 | 120.00 | - | Reiterates |
| 01 Nov | Peel Hunt | Buy | 56.55 | 120.00 | - | Reiterates |
| 17 Oct | RBC Capital Markets | Sector Performer | 56.55 | 86.00 | 81.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 17 Jul 2017 | Steven Harris | Exercise | 535,375 @ 0.08p | £428.30 |
| 18 Sep 2015 | Charles Swingland | Sell | 1,230,000 @ 318.24p | £3,914,352.00 |
| 18 Sep 2015 | Charles Swingland | Sell | 9,000 @ 318.72p | £28,684.80 |
| 18 Sep 2015 | Charles Swingland | Sell | 754,548 @ 320.24p | £2,416,364.52 |
| 27 Mar 2014 | Dr Rod Hafner | Exercise | 212,375 @ 0.08p | £169.90 |
